• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GAMBRO RENAL PRODUCTS REVACLEAR; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GAMBRO RENAL PRODUCTS REVACLEAR; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Model Number UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Rash (2033); Vomiting (2144); Loss of consciousness (2418)
Event Date 03/07/2017
Event Type  Injury  
Manufacturer Narrative
Na.
 
Event Description
A hemodialysis (hd) patient has been experiencing multiple allergic reactions of unknown origin at various levels of severity.The patient¿s hd nurse reported that the patient¿s reactions are ¿very random,¿ occurring at various times including prior to hd treatment, during hd treatment, and post hd treatments, including reactions at the patient¿s home and on days the patient did not receive hd treatments.The reactions include the following symptoms at various times and degrees (not further specified): welts/hives/rash all over body, itching, lips and facial swelling, raspy voice, nausea and vomiting, unstable blood pressure or drop in blood pressure, convulsions, and normal saline boluses in the presence of fluid overloaded.In addition, it was reported that the patient will ¿just pass out¿, including one time when the patient fell out of their wheelchair (date unknown).The patient was hospitalized for five days related to the multiple allergic reactions.When the patient returned to the clinic for hd treatment (after hospitalization) the dialyzer was changed to the revaclear dialyzer.However, the hd nurse reports that the patient continues to have all the same reactions with the revaclear dialyzer.During treatment, the patient has received micera (occasionally), doxercalciferol, diphenhydramine (intravenously prior to hd treatment), acetaminophen, and midodrine prn.No additional information is available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REVACLEAR
Type of Device
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
GAMBRO RENAL PRODUCTS
1101 jeter avenue
opelika AL
Manufacturer (Section G)
GAMBRO RENAL PRODUCTS
1101 jeter avenue
opelika AL 36801
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 60073
2242702068
MDR Report Key6565460
MDR Text Key75091302
Report Number3006552611-2017-00005
Device Sequence Number1
Product Code KDI
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K072232
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Health Professional
Type of Report Initial
Report Date 05/12/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/13/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNKNOWN
Device Catalogue NumberASKU
Device Lot NumberASKU
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/17/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age75 YR
Patient Weight117
-
-